Big Pharma and Biotech’s are looking at alternative routes of administration for proteins (e.g.,
monoclonal antibodies) and oligonucleotides (e.g. Antisense Oligonucleotides) to treat diseases
of the respiratory tract.

A plethora of well-established inhalation devices and formulation technologies can be optimized
to enable the aerosolization of proteins and oligonucleotides, at the same time not impacting
the structures of these entities and maintaining efficacy.

Traditionally, small molecules have been dominating the market of inhaled drugs. Therefore,
contract testing organizations specialized in testing these drugs mostly have labs, capable of
testing small molecules.

A&M STABTEST however is different!

With our +15 years of experience in the field of inhaled drug testing, as well as +20 years of
protein and +10 years of nucleic acid QC-testing, we bring the required knowhow to the table to
make your inhaled protein or oligonucleotide project a success.

We offer:

• Dedicated laboratory of inhaled drug analysis (temperature and humidity controlled)
• Testing of aerosols (APSD, DD, Droplet Size, Spray Plume; Artificial Lung)
• Protein characterization by LC-MS
• Oligonucleotide assay, purity and impurities by LC-MS
• Capillary electrophoresis (cIEF by Maurice, CGE-SDS (red / non-red))
• HPLC/UPLC (SEC, CEX, IP-RP)
• Potency (ELISA, Cell-based assay)

Put our inhaled drug testing and decades of experience in protein and nucleic acid QC-analysis
to the test!